SUNITINIB PLIVA

Capsule, hard, 25 mg
RestrictedActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength25 mg
PackagingUkupno 28 kapsula tvrdih u blisteru djeljivom na pojedinačne doze (4x7) u kartonskoj kutiji
ManufacturerTeva Operations Poland Sp. z o.o., Poland
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateFebruary 13, 2023

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register